TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

345.80$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow KRYS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – +62.7%
– +1,050.0% +513.0% +430.5% +147.5% +49.6% +46.4% +23.5% +34.1% -2.4%
– +645.5% +222.0% +56.4% +164.1% +368.2% +116.9% +20.2% +23.0% +11.0%
– +8,672.5% -77.4% +64.9% +205.5% +321.3% +93.6% – – –
– – +2.6% -428.6% – +121.1% +37.0% -1,447.6% – –
– +1,300.0% +963.8% +186.4% +132.0% +360.4% -22.5% -77.7% -64.1% +182.0%
– +1,300.0% +4,815.7% -51.9% +125.1% +1,928.2% -49.7% – -297.8% -64.3%
– – – – – – – – – –
– +3,418.4% +49.3% +45.6% +9.8% +201.3% – – – –
– +24.7% – – – – – – – –
– +1,493.4% +42.6% +45.6% +9.8% +194.6% -89.8% +473.6% -86.7% -67.8%
– +2,378.8% +13.4% +55.0% -3.7% -9.6% -345.8% – -106.9% –
– – – – – – – – – +58.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?